Cathie Wood Dumps $142 Million of Twitter Stock Before Earnings

image

(Bloomberg) — Cathie Wood stepped up selling of social media platform Twitter Inc. shares days before its earnings.

Wood’s firm ARK Investment Management LLC sold nearly 4 million Twitter shares on Monday, the most in one day since at least May, according to trading data from ARK compiled by Bloomberg. The social-media company is set to announce its earnings on Thursday.

Wood’s flagship ARK Innovation ETF dumped 3.66 million shares of Twitter on Monday, while the ARK Next Generation Internet ETF sold more than 280,000 shares, according to the asset manager’s daily trading updates. That amounted to about $142 million based on Monday’s closing level.

The selling comes amid a mixed set of results from its social-media peers. Facebook’s parent Meta Platforms Inc. suffered biggest one-day crash in stock-market history last week as its user base stopped growing while Snap Inc. jumped most ever after giving a quarterly sales forecast that topped Wall Street’s projections.

ARK has been selling Twitter shares almost every week since late December and its sales have picked up pace this month. Apart from Monday, ARK sold more than 2 million shares of Twitter on Feb. 3 and more than 700,000 shares on Feb. 2.

The firm’s daily trading updates show only active decisions by the management team and do not include creation or redemption activity caused by investor flows. Wood’s oft-repeated mantra is that ARK invests with at least a five-year time horizon, and that volatility in their equity picks is expected.

ARK’s flagship fund has struggled in the past year after advancing nearly 150% in 2020, after investors started dumping pricey tech stocks and switching to cyclical firms expected to be bigger beneficiaries of an economic recovery.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More